Innovations to Explore Orphazyme ApS in Upcoming Episode on Healthcare

Share Article

DMG Productions discovers the latest breakthroughs in healthcare.

News Image

Innovations with Ed Begley Jr. announced today that they will feature Orphazyme ApS in an upcoming episode, airing third quarter 2016 via Discovery Channel. Dates and show times TBA.

Orphazyme ApS was founded in June 2009 with the aim of developing heat shock protein based therapy for the treatment of diseases caused by defects in the function and/or metabolism of proteins.

In this episode of Innovations viewers will be educated on Orphazyme’s development programs, which target diseases that are associated with aberrations in the protein homeostasis, such as characterized by loss-of-function of one or more proteins or the formation of protein-containing aggregates.

“We are very excited to educate people about the efforts it takes to develop innovative new drugs for patients suffering from these detrimental diseases,” said Thomas Kirkegaard, Founder and Chief Scientific Officer of Orphazyme. “Discovering and understanding novel aspects of human biology and translating this into potential therapies is a herculean effort, which demands that all good forces act together and strive towards the same goal - a safe and efficacious treatment for these terrible diseases.”

“Orphazyme is pioneering heat shock protein based therapies to become a leading biopharmaceutical company,” said Michele Nehls, Senior Producer for the series. “The company is dedicated to the development of paradigm-changing medicines to improve the life of affected patients and their families. We look forward to bringing this information to our audiences.”

About Orphazyme:
Orphazyme ApS is a Danish biopharmaceutical company, which develops paradigm-changing medicines for the treatment of genetic diseases. The lead program is in late stage clinical development as a novel therapy for lysosomal storage diseases. This family of rare, genetic disorders consists of more than 50 diseases, often affecting children. Most of these diseases are currently untreatable and often severely debilitating and fatal. Orphazyme has raised more than $40 million in financing from a strong investor base, including Novo A/S, Sunstone Capital, Aescap Venture, Kurma Partners and Idinvest Partners. For more information, visit:

About Innovations and DMG Productions:
Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Featuring practical solutions and important issues facing consumers and professionals alike, Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.

DMG Productions (responsible for creating the Innovations show) includes personnel specialized in various fields from agriculture to medicine, independent films to regional news and more. Field producers work closely with experts in the field to develop stories. This powerful force enables DMG to consistently produce commercial-free, educational programming that both viewers and networks depend on.

For more information visit: or contact Michele Nehls at (866) 496-4065 x 822 or via email at Michele(at)InnovationsTelevision(dot)com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michele Nehls
DMG Productions
+1 866-496-4065 Ext: 802
Email >
Visit website